CALYPTE BIOMEDICAL CORP·4

Dec 3, 6:06 AM ET

CALYPTE BIOMEDICAL CORP 4

4 · CALYPTE BIOMEDICAL CORP · Filed Dec 3, 2007

Insider Transaction Report

Form 4
Period: 2007-11-28
KARAS ADEL
DirectorPresident and CEO
Transactions
  • Award

    Non-Qualified Stock Option

    2007-11-28+3,000,0001,500,000 total
    Exercise: $0.11From: 2007-11-28Exp: 2017-11-28Common Stock (3,000,000 underlying)
Footnotes (1)
  • [F1]Represents option to purchase common stock. Options to purchase 1,500,000 shares are immediately exercisable; options to purchase 750,000 shares become exercisable on 11/28/08, the first anniversary of the grant, and options to purchase 750,000 shares become exercisable on 11/28/09, the second anniversary of the grant.

Documents

1 file
  • 4
    v096031_ex.xmlPrimary